Literature DB >> 11836001

Distribution of urocortin in the rat's gastrointestinal tract and its colocalization with tyrosine hydroxylase.

Tamás Kozicz1, Akira Arimura.   

Abstract

Urocortin (Ucn), a newly identified member of the corticotropin-releasing factor (CRF) family, is not only expressed in the brain, but also abundantly present in the peripheral tissues, especially in the gastrointestinal tract (GI) as determined by radioimmuoassay. In order to determine the precise localization of urocorin in the GI, we mapped the distribution of urocortin-like immunoreactivity (ir) in the GI of the rat using an immunofluorescence histochemical technique. Ucn, both in the brain and the peripheral tissues, is involved in the regulatory control of host-defense mechanism during stress. In order to study the possible involvement of the sympathetic system in the expression of GI urocortin in response to stress, we examined the effect of chemical sympathectomy on urocortin-ir and its colocalization with tyrosine hydroxylase (TH). UCn was expressed in all parietal cells of the stomach, myenteric and submucosal plexuses as well as in cells in Lieberkühn crypts of the small and large intestine. Most of the acid secreting parietal cells contained both Ucn and TH. Chemical sympathectomy did not affect Ucn immunoreactivity of parietal cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836001     DOI: 10.1016/s0196-9781(01)00639-8

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  16 in total

Review 1.  Corticotropin-releasing factor receptors and stress-related alterations of gut motor function.

Authors:  Yvette Taché; Bruno Bonaz
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 2.  Minireview: Dopaminergic regulation of insulin secretion from the pancreatic islet.

Authors:  Alessandro Ustione; David W Piston; Paul E Harris
Journal:  Mol Endocrinol       Date:  2013-06-06

Review 3.  The corticotropin releasing factor system in cancer: expression and pathophysiological implications.

Authors:  Athina Kaprara; Kalliopi Pazaitou-Panayiotou; Alexandros Kortsaris; Ekaterini Chatzaki
Journal:  Cell Mol Life Sci       Date:  2010-02-09       Impact factor: 9.261

4.  Anti-incretin, Anti-proliferative Action of Dopamine on β-Cells.

Authors:  Antonella Maffei; Ann Marie Segal; Juan Carlos Alvarez-Perez; Adolfo Garcia-Ocaña; Paul E Harris
Journal:  Mol Endocrinol       Date:  2015-03-09

5.  Enhanced pelvic responses to stressors in female CRF-overexpressing mice.

Authors:  M Million; L Wang; M P Stenzel-Poore; S C Coste; P Q Yuan; C Lamy; J Rivier; T Buffington; Y Taché
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-12-28       Impact factor: 3.619

6.  Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF2 receptors without malaise and stress.

Authors:  E M Fekete; Y Zhao; A Szücs; V Sabino; P Cottone; J Rivier; W W Vale; G F Koob; E P Zorrilla
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

7.  Urocortin 1 modulates immunosignaling in a rat model of colitis via corticotropin-releasing factor receptor 2.

Authors:  Jen Chang; Melanie R Adams; Matthew S Clifton; Min Liao; Julia H Brooks; Burcu Hasdemir; Aditi Bhargava
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-17       Impact factor: 4.052

8.  Urocortins and CRF type 2 receptor isoforms expression in the rat stomach are regulated by endotoxin: role in the modulation of delayed gastric emptying.

Authors:  Pu-Qing Yuan; S Vincent Wu; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-04-19       Impact factor: 4.052

9.  Postnatal developmental profile of urocortin 1 and cocaine- and amphetamine-regulated transcript in the perioculomotor region of C57BL/6J mice.

Authors:  Anita Cservenka; Erika Spangler; Dawn M Cote; Andrey E Ryabinin
Journal:  Brain Res       Date:  2010-01-11       Impact factor: 3.252

Review 10.  Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity.

Authors:  Suleman Chaudhry; Marilia Bernardes; Paul E Harris; Antonella Maffei
Journal:  Minerva Endocrinol       Date:  2015-10-27       Impact factor: 2.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.